Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study

Table 5 Incidence of Adverse Events (Safety Population)

	Previously Treated Patients		Total Study Population
Incidence, %	DEX 0.7	Sham	DEX 0.7	Sham
	n = 247	n = 261	n = 347	n = 350
Serious ocular AE	6.9	0.8	6.9	1.1
IOP-related AE^a	38.1	4.6	36.0	5.1
Cataract-related AE (incidence in phakic eyes)	70.3	20.1	67.9	20.4

^aAny adverse event (AE) related to increased intraocular pressure or glaucoma
AE adverse event, DEX 0.7 dexamethasone intravitreal implant 0.7 mg, IOP intraocular pressure

ISSN: 1471-2415